Medicina interna
Servizo
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (47)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
-
Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis
Autoimmunity Reviews
-
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors
Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912
2023
-
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival
Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703
2022
-
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)
Scientific Reports
-
Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program
Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy
Journal of Gastrointestinal Surgery, Vol. 26, Núm. 2, pp. 286-297
-
SEA 2022 Standards for Global Control of Cardiovascular Risk
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
-
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)
PLoS ONE, Vol. 17, Núm. 12 December
2021
-
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
Scientific Reports, Vol. 11, Núm. 1
-
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
Joint Bone Spine, Vol. 88, Núm. 6
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
Impact of the COVID-19 pandemic on tuberculosis management in Spain
International Journal of Infectious Diseases, Vol. 108, pp. 300-305
-
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial
BMJ Open, Vol. 11, Núm. 8
-
New horizons in the pharmaceutical care of HIV patients on long-term antiretroviral treatment
Farmacia Hospitalaria
-
Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection
Medicine, Vol. 100, Núm. 46, pp. e27838
-
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880
-
Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study
Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 517-528